We believe that this study fully informs our understanding of neural mechanisms of behavioral change in aging human subjects by providing important data on the impact of genotype (in this case BDNF genotypes, including val66met and genotypes from another growth factor, NGF) on aging on transcriptional profiles in brain tissue, brain structure, neurocognition, and response to an exercise based treatment. This account will not only be mechanistic, but it will be fully translational in that it begins with 1. a molecular understanding of BDNF genotype modulate expression patterns in approximately 48000 cortical transcripts as determined by microarray profiling of human post mortem samples;2. examines the impact of age x BDNF genotypes on neuroanatomic volumes in structural MRI and neurocognition with an emphasis on episodic memory and medial temporal lobe structures and affect regulation;and includes 3. a proof of concept randomized trial examining the impact of physical exercise (designed to increase BDNF expression) and BDNF genotypes on cognitive endpoints. If the predictions in these studies are correct, we believe that we will have practical, personalized treatments to improve memory in older populations

Public Health Relevance

This project aims to understand behavioral changes associated with aging from the standpoint of individual differences in genotype. To do this we assess the impact of different variants of a gene known to be important for memory on cognition, brain structure, and brain neurochemistry and how these interact with age. Importantly, we will also determine if the impact of a physical exercise program designed to improve mental fitness can be modulated by BDNF genotype.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG038734-03
Application #
8523730
Study Section
Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section (NPAS)
Program Officer
Wagster, Molly V
Project Start
2011-09-15
Project End
2016-05-31
Budget Start
2013-09-01
Budget End
2014-05-31
Support Year
3
Fiscal Year
2013
Total Cost
$256,023
Indirect Cost
$88,777
Name
Feinstein Institute for Medical Research
Department
Type
DUNS #
110565913
City
Manhasset
State
NY
Country
United States
Zip Code
11030
Zhang, Nan; Gordon, Marc L; Ma, Yilong et al. (2018) The Age-Related Perfusion Pattern Measured With Arterial Spin Labeling MRI in Healthy Subjects. Front Aging Neurosci 10:214
Gomar, Jesus J; Ragland, J Daniel; Ulu?, Aziz M et al. (2017) Differential medial temporal lobe morphometric predictors of item- and relational-encoded memories in healthy individuals and in individuals with mild cognitive impairment and Alzheimer's disease. Alzheimers Dement (N Y) 3:238-246
Gomar, Jesus J; Conejero-Goldberg, Concepcion; Davies, Peter et al. (2016) Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease. J Alzheimers Dis 51:1085-97
Gomar, Jesus J; Conejero-Goldberg, Concepcion; Huey, Edward D et al. (2016) Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease. Neurobiol Aging 39:165-73
Kantarci, Kejal; Goldberg, Terry E (2016) MR spectroscopy, APOE genotype, and evolving ?-amyloid pathology: What is being detected and when. Neurology 86:1750-1
Gomar, Jesus J; Gordon, Marc L; Dickinson, Dwight et al. (2014) APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain. Biol Psychiatry 75:686-92
Gomar, Jesus J; Conejero-Goldberg, Concepcion; Davies, Peter et al. (2014) Extension and refinement of the predictive value of different classes of markers in ADNI: four-year follow-up data. Alzheimers Dement 10:704-12
Gomar, Jesus J; Harvey, Philip D; Bobes-Bascaran, Maria T et al. (2011) Development and cross-validation of the UPSA short form for the performance-based functional assessment of patients with mild cognitive impairment and Alzheimer disease. Am J Geriatr Psychiatry 19:915-22